Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnology, the brain and the future.

Susan A Greenfield1

  • 1Oxford University Department of Pharmacology, Mansfield Road, Oxford, OX1 3QT, UK.

Trends in Biotechnology
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Differential Impact of Three Different Anesthetics on Large-Scale Neuronal Activity Measured Using Voltage-Sensitive Dye Imaging in Rat Brain Slices.

Anesthesia and analgesia·2025
Same author

A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice.

Neurobiology of aging·2024
Same author

A novel peptide 'T14' reflects age and photo-aging in human skin.

Aging·2023
Same author

A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential.

Alzheimer's & dementia (New York, N. Y.)·2022
Same author

A Multidisciplinary Approach Reveals an Age-Dependent Expression of a Novel Bioactive Peptide, Already Involved in Neurodegeneration, in the Postnatal Rat Forebrain.

Brain sciences·2018
Same author

Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer's Disease.

Frontiers in neuroscience·2018

New molecular biology, informatics, and nanoscience advances offer novel treatments for central nervous system diseases. Future nanotechnology and brain-computer interfaces promise revolutionary neuropharmacology, raising unique ethical considerations.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Nanoscience
  • Informatics

Background:

  • Central nervous system (CNS) diseases require innovative therapeutic strategies.
  • Traditional neuropharmacology faces limitations in targeting complex brain functions.

Purpose of the Study:

  • To explore emerging technologies applicable to CNS diseases.
  • To discuss the potential impact of novel therapies and interfaces on neuropharmacology.
  • To highlight the technological and ethical challenges in 21st-century neuroscience.

Main Methods:

  • Review of recent advances in molecular biology, informatics, and nanoscience.
  • Analysis of novel drug classes, stem cell therapies, and gene therapies.
  • Exploration of nanotechnology applications, including miniaturized devices and carbon-silicon interfaces.

Related Experiment Videos

Main Results:

  • New therapeutic approaches are applicable to CNS diseases, expanding beyond transmitter modification.
  • Stem cell and gene therapies offer enhanced targeting selectivity.
  • Nanotechnology promises new medicines, monitoring/screening devices, and novel delivery routes.

Conclusions:

  • Advancements in molecular biology, informatics, and nanoscience are revolutionizing CNS disease treatment.
  • Future neuropharmacology will be significantly impacted by nanotechnology and brain-computer interfaces.
  • The complexity of the brain presents unique technological and ethical questions for future research.